A Web-Based Intervention to Prevent Drug Abuse Among Adolescent Girls
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01813123|
Recruitment Status : Active, not recruiting
First Posted : March 18, 2013
Last Update Posted : January 25, 2018
This study is designed to develop and test a gender-specific, web-based drug abuse prevention program. Study participants will be adolescent girls aged 13 and 14 years who will complete all measures online. Randomly assigned girls will also interact online with a skills-based program and subsequent annual booster sessions.
The study's primary hypothesis is that rates of 30-day alcohol and drug use will be lower among girls assigned to receive the intervention.
|Condition or disease||Intervention/treatment||Phase|
|Drug Abuse Prevention||Behavioral: RealTeen||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||788 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||A Web-Based Intervention to Prevent Drug Abuse Among Adolescent Girls|
|Study Start Date :||March 2013|
|Actual Primary Completion Date :||July 2017|
|Estimated Study Completion Date :||January 2018|
|No Intervention: Control|
A web-based, gender-specific program intended improve girls' cognitive and behavioral skills. Each of the 9 sessions requires approximately 20 minutes. After initial intervention, girls will receive two annual booster sessions (i.e., a 20-minute review of previously learned material indexed to new age).
- 30-day alcohol and drug use [ Time Frame: Up to 3 years ]Measures will ask girls to report, for the past 30 days, the number of: drinks of alcohol consumed, cigarettes smoked, puffs of marijuana, and times they consumed four or more drinks within 2 hours. Girls will also report past 30-day use of: inhalants, ecstasy, club drugs, prescription drugs for recreational use, heroin, and hallucinogens.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01813123
|United States, New York|
|Columbia University School of Social Work|
|New York, New York, United States, 10027|
|Principal Investigator:||Traci M Schwinn, PhD||Columbia University|